Extracorporeal Membrane Oxygenation Machine Market Players:
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Getinge AB
- LivaNova PLC
- Terumo Corporation
- Xenios AG
- Microport Scientific Corporation
- Eurosets S.r.l.
- Johnson & Johnson
- Abbott
- Fresenius Medical Care
The competitive landscape of the extracorporeal membrane oxygenation machine market is rapidly evolving as established key players, health giants, and new entrants are investing in advanced technologies. Key players in the market are focused on catering to the stringent regulatory norms and consumer demand. These key players are adopting several strategies such as mergers and acquisitions, joint ventures, partnerships, and novel product launches to enhance their product base and strengthen their market position. Here are some key players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of extracorporeal membrane oxygenation machine is estimated at USD 508.3 million.
The global extracorporeal membrane oxygenation machine market size crossed USD 487.67 million in 2025 and is likely to register a CAGR of more than 4.7%, exceeding USD 771.96 million revenue by 2035.
Asia Pacific extracorporeal membrane oxygenation machine market will hold more than 36% share by 2035, driven by partnerships, technology transfer, and rising incidence of respiratory diseases.
Key players in the market include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Xenios AG, Microport Scientific Corporation, Eurosets S.r.l., Johnson & Johnson, Abbott, Fresenius Medical Care.
